Important note: Information in this article was accurate in 2009. The state of the art may have changed since the publication date.
|
|
Reuters (10.22.09) - Friday, October 23, 2009
Tan Ee Lyn
"With a brief pulse of electricity, our cell membrane temporarily opens up and allows a lot more of the DNA to get inside," said Sandhya Vasan of the Aaron Diamond AIDS Research Center in New York. "The reason why DNA vaccines by themselves don't trigger a powerful immune response is because most of [the DNA] does not get inside our cells."
When injected alone, the vaccine produced an immune response in 25 percent of participants. When the same vaccine was injected in combination with electroporation, that rate increased, Vasan said.
"We improved the response rate, improved the duration of the response, and it also improved the breadth of the response," said Vasan. "There were four different genes of the virus, [and] for the highest dose, people were responding to three or even four of the genes."
Among 40 volunteers evenly divided into five groups, three of the groups received varying vaccine doses with electroporation; the fourth group was given a placebo plus electroporation; and the fifth was given a conventional injection but with the highest dose.
Those who got a traditional injection showed no immune response; three out of the eight participants given the lowest dose electroporally formed a response; and everyone given the highest dose with electroporation had a response.
"This is the first clinical trial of electroporation in healthy volunteers for a preventative vaccine," Vasan said. "It can be applied to many diseases, many vaccines, not just for HIV." Her group next plans to conduct a Phase II trial of a stronger DNA vaccine delivered with electroporation.
091023
AD091826
Copyright © 2009 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from the Elton John AIDS Foundation, National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
Always watch for outdated information. This article first appeared in 2009. This material is designed to support, not replace, the relationship that exists between you and your doctor.AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2009. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.
.